[1]
“SGLT2 INHIBITORS AND MYOCARDIAL REMODELING IN PROSTATE CANCER PATIENTS: THE ROLE OF SPECKLE TRACKING ECHOCARDIOGRAPHY (GLS)”, NUJM, vol. 1, no. 3, pp. 71–76, Dec. 2025, Accessed: Dec. 20, 2025. [Online]. Available: https://ijournal.uz/index.php/nujm/article/view/2575